Marvel Biosciences Corp. – TSX:MRVL.V
Marvel Biosciences Corp. stock price today
Marvel Biosciences Corp. stock price monthly change
Marvel Biosciences Corp. stock price quarterly change
Marvel Biosciences Corp. stock price yearly change
Marvel Biosciences Corp. key metrics
Market Cap | 4.46M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -0.05 |
Revenue | N/A |
EBITDA | -2.21M |
Income | -2.30M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeMarvel Biosciences Corp. stock price history
Marvel Biosciences Corp. stock forecast
Marvel Biosciences Corp. financial statements
| Apr 2023 | 0 | -716.32K | |
|---|---|---|---|
| Jul 2023 | 0 | -1.04M | |
| Jan 2024 | 0 | -232.81K | |
| Apr 2024 | 0 | -307.31K |
| Apr 2023 | 1220295 | 1.74M | 143.32% |
|---|---|---|---|
| Jul 2023 | 672389 | 2.39M | 355.82% |
| Jan 2024 | 711158 | 3.16M | 445.13% |
| Apr 2024 | 347268 | 3.10M | 893.99% |
| Apr 2023 | -296.14K | 0 | 1M |
|---|---|---|---|
| Jul 2023 | -445.56K | 0 | 0 |
| Jan 2024 | -239.31K | 0 | 500K |
| Apr 2024 | -359.98K | 0 | 0 |
Marvel Biosciences Corp. other data
-
What's the price of Marvel Biosciences Corp. stock today?
One share of Marvel Biosciences Corp. stock can currently be purchased for approximately $0.11.
-
When is Marvel Biosciences Corp.'s next earnings date?
Unfortunately, Marvel Biosciences Corp.'s (MRVL.V) next earnings date is currently unknown.
-
Does Marvel Biosciences Corp. pay dividends?
No, Marvel Biosciences Corp. does not pay dividends.
-
How much money does Marvel Biosciences Corp. make?
Marvel Biosciences Corp. has a market capitalization of 4.46M.
-
What is Marvel Biosciences Corp.'s stock symbol?
Marvel Biosciences Corp. is traded on the TSX under the ticker symbol "MRVL.V".
-
What is Marvel Biosciences Corp.'s primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Marvel Biosciences Corp.?
Shares of Marvel Biosciences Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
When Marvel Biosciences Corp. went public?
Marvel Biosciences Corp. is publicly traded company for more then 4 years since IPO on 13 Jul 2021.
-
What is Marvel Biosciences Corp.'s official website?
The official website for Marvel Biosciences Corp. is marvelbiotechnology.com.
-
Where are Marvel Biosciences Corp.'s headquarters?
Marvel Biosciences Corp. is headquartered at 505 8th Avenue S.W., Calgary, AB.
-
How can i contact Marvel Biosciences Corp.?
Marvel Biosciences Corp.'s mailing address is 505 8th Avenue S.W., Calgary, AB.
Marvel Biosciences Corp. company profile:
Marvel Biosciences Corp.
marvelbiotechnology.comTSX
0
Biotechnology
Healthcare
Marvel Biosciences Corp. operates as a pre-clinical stage pharmaceutical development biotechnology company. It engages in the discovery and development of synthetic derivative compounds of known drugs that inhibit the A2a adenosine receptor. The company offers Nourianz (Istradefylline, KW-6002) and MB-204 an adenosine A2A receptor antagonist. It targets neurological diseases, such as Alzheimer's disease, depression and anxiety, and non-neurological conditions of cancer; and non-alcoholic steatohepatitis. Marvel Biosciences Corp. is headquartered in Calgary, Canada.
Calgary, AB T2P 1G2
:
ISIN: CA57384M1077
:
